D'Haens, G R <br/><br/>
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.  [electronic resource] 

 -  Journal of Crohn's & colitis  Jun 2010 
 - 153-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2009.09.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Anti-Inflammatory Agents--administration & dosage<br/>Biomarkers--metabolism<br/>Biopsy<br/>Budesonide--administration & dosage<br/>C-Reactive Protein--metabolism<br/>Colitis, Ulcerative--drug therapy<br/>Colonoscopy<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Intestinal Mucosa--pathology<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Remission Induction<br/>Severity of Illness Index<br/>Tablets, Enteric-Coated<br/>Treatment Outcome